With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

The market is projected to grow from $11B in 2024 to $40B by 2030, driven by both conventional bispecifics and advancements such as antibody-drug and ... Antibody Discovery process can align ...

Biohaven is a biopharmaceutical company focused on the discovery ... including SMA and obesity; antibody recruiting bispecific molecules and antibody drug conjugates for cancer.

Abcellera, for example, designed Lily’s COVID antibody ... business of drug discovery, find promising targets, and then sell them to pharma to carry out the expensive process of development ...

Miniaturization is a key consideration for reducing screening cost and increasing throughput during the drug-discovery process ... Moreover, the high antibody density on beads creates an avidity ...

AI tools are being combined into virtual screening platforms that can accelerate multiple steps in the drug discovery process ... with a PredAI that can model antibody-antigen interactions ...

The leading drug candidates vetted by in vitro testing, are capable of neutralizing viruses. The peer-reviewed discovery of the ... to learn more about our process.

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.